Farahani P. LACK OF HEALTH-RELATED QUALITY OF LIFE AND PATIENT-CENTRED OUTCOME MEASURES IN RANDOMIZED CONTROLLED TRIALS CONDUCTED FOR DIABETES PHARMACOTHERAPY: SGLT-2 RECEPTOR INHIBITORS AS AN EXAMPLE. J Popl Ther Clin Pharmacol. 2018;24(1). Accessed September 20, 2025. https://jptcp.com/index.php/jptcp/article/view/132